Literature DB >> 13835935

5, 5-Diphenylhydantoin (dilantin) blood levels after oral or intravenous dosage in man.

O SVENSMARK, P J SCHILLER, F BUCHTHAL.   

Abstract

Entities:  

Keywords:  HYDANTOINS/blood

Mesh：

Substances：

Year:  1960        PMID： 13835935     DOI： 10.1111/j.1600-0773.1960.tb01218.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  10 in total

1.  The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Authors:  E H Reynolds
Journal:  Proc R Soc Med       Date:  1975-02

2.  The levels of anticonvulsants in breast milk.

Authors:  S Kaneko; T Sato; K Suzuki
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

Review 3.  Recent progress in epilepsy. Diagnostic procedures and treatment.

Authors:  B R Tharp
Journal:  Calif Med       Date:  1973-07

Review 4.  Current trends in Australian neurology.

Authors:  G Selby
Journal:  Postgrad Med J       Date:  1970-04       Impact factor: 2.401

5.  Laboratory control of anticonvulsant dosage.

Authors:  M J Eadie
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Effect of diphenylhydantoin on hepatic drug hydroxylation.

Authors:  F Petruch; R V Schüppel; G Steinhilber
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

7.  Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.

Authors:  E Karlsson
Journal:  Br Heart J       Date:  1975-07

8.  [Plasma concentrations after injection or infusion of phenytoin (author's transl)].

Authors:  D Schmidt; A Vogel
Journal:  Klin Wochenschr       Date:  1977-03-01

9.  Plasma protein binding of phenytoin in 100 epileptic patients.

Authors:  G M Peterson; S McLean; S Aldous; R J Von Witt; K S Millingen
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 10.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.